SPECIAL REPORT on Aducanumab Approval: Discussion with Cognitive Behavioral Neurologists Dr. Jeff Burns, Director of the University of Kansas Alzheimer’s Disease Center, speaks with Dr. Ron Petersen, Director of the Mayo Clinic Alzheimer's Disease Center, about the recent FDA approval of aducanumab for the treatment of Alzheimer disease. June 19, 2021 Issue Neurology, Journal, Podcast Listen11:31 Disclosures View Recent Podcasts
